Navigation Links
BL Healthcare's Next Generation of Wireless Remote Healthcare Solutions, Now on Verizon Wireless' 4G LTE Mobile Broadband Network
Date:1/5/2011

LAS VEGAS and BASKING RIDGE, N.J., Jan. 5, 2011 /PRNewswire/ -- From the 2011 International Consumer Electronics Show (CES), BL Healthcare, Inc. today announced its 4G LTE-enabled TCx-I Healthcare Access Terminal that delivers multi-point HD video conferencing with simultaneous sharing of medical telemetry between remote patients and their caregivers.

BL Healthcare has developed the first and only HD video-enabled telemedicine Ecosystem.  The BL Ecosystem solution allows patients to securely receive professional medical care in their homes, at work, in small clinics, or at nursing and assisted living homes.  BL Ecosystem partners supply medical peripherals and unique care applications for disease management.  BL customers can develop and maintain their unique intellectual property in the BL Ecosystem and bring these unique solutions to market through the BL Ecosystem.

The BL Healthcare Access Terminal is an integrated, easy-to-use, highly interactive system that empowers the patient to take a more proactive role in the management of his or her care plan.  The system includes functionality such as HD multi-point video conferencing, multimedia support for educational programs, instant messaging, real-time alerts and notifications, and the ability to communicate with a wide range of vital sign measurement and peripheral medical devices.

The Verizon Wireless 4G LTE Mobile Broadband network, launched in December 2010, is the fastest, most advanced 4G network in the United States, providing speeds up to 10 times faster than Verizon Wireless' 3G network. Verizon Wireless' 4G LTE Mobile Broadband network currently reaches one-third of all Americans, with plans to expand the network to the company's entire 3G coverage area over the next three years.

This solution is a result of collaboration fostered at Verizon Wireless' LTE Innovation Center.  The LTE Innovation Center, established in 2008, provides an environment for diverse companies to work together to develop innovative products that leverage 4G LTE technology.  

The TCx-I Healthcare Access Terminal will be highlighted from Jan. 6-9 in Verizon Wireless' booth (#35216 in the South Hall of the Las Vegas Convention Center) at CES.  For more information about the LTE Innovation Center and Verizon Wireless' 4G LTE network, visit www.verizonwireless.com/lte.

About Verizon Wireless

Verizon Wireless operates the nation's fastest and most advanced 4G network and largest and most reliable 3G network, and serves more than 93 million customers. Headquartered in Basking Ridge, N.J., with 80,000 employees nationwide, Verizon Wireless is a joint venture of Verizon Communications (NYSE, Nasdaq: VZ) and Vodafone (LSE, Nasdaq: VOD).  For more information, visit www.verizonwireless.com. To preview and request broadcast-quality video footage and high-resolution stills of Verizon Wireless operations, log on to the Verizon Wireless Multimedia Library at www.verizonwireless.com/multimedia.

About BL Healthcare

BL Healthcare (www.blhealthcare.com), based in Foxboro, Mass., is a leading provider of next generation remote health management solutions to the Healthcare Industry.  Leveraging the convergence of the Internet, Broadband technology, and Open Systems, BL Healthcare provides innovative solutions for linking members, providers, and caregivers for the monitoring and management of wellness and disease states at distributed points of healthcare access, particularly in the patient's home. For further information, please contact BL Healthcare at (508) 543-4150 – info@BLHealthcare.com.


'/>"/>
SOURCE Verizon Wireless
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
3. Beaumont Patients 1st to get Next Generation of Radiation Treatment
4. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
5. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
6. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis
7. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
8. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
9. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
10. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
11. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):